Skip to Content

Join the 'Elidel' group to help and get support from people like you.

Elidel News

Hawaii Facing Rise in Dengue Fever Cases

Posted 3 Dec 2015 by Drugs.com

THURSDAY, Dec. 3, 2015 – Do your winter travel plans include Hawaii? You may want to pack bug repellent, experts say. That's because the Big Island of Hawaii is facing an outbreak of dengue fever – a mosquito-borne virus that can cause terrible headache and crushing pain in the muscles and joints. State health officials have confirmed 117 cases of dengue fever on the Big Island since mid-September, including 103 local residents and 14 visitors to the island. One other case has been reported on the island of Oahu, but health officials say it was not locally transmitted and is not tied to the new outbreak. The jump in cases has prompted top experts from the U.S. Centers for Disease Control and Prevention to visit the island this week to try and help, CNN reported Wednesday. "I don't think travelers should be overly worried, but they should take care to avoid mosquitoes as much as ... Read more

Related support groups: Therapeutic, Hypercare, Sulfur, Drysol, Rogaine, Psoriasin, Calamine, Vaniqa, Capsaicin, Zinc Oxide, Arnica, Viral Infection, Protopic, Elidel, Desitin, Calmoseptine, Capzasin, Selenium Sulfide, Coal Tar, Benzoin

Retail Prices of Dermatology Drugs Skyrocket

Posted 25 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to price inflation, up 279 percent between 2011 and 2014, based on the drugs surveyed. Price increases for skin treatments far outpaced the general inflation rate of 11 percent during the six-year study period, the researchers said. "Cancer drugs were the worst in terms of the numbers" – up 1,240 percent or nearly $11,000 over the six-year study period – primarily because of two medicines, said Dr. Steven Rosenberg, voluntary professor of dermatology at the University of Miami Miller School of ... Read more

Related support groups: Monistat, RID, Monistat 3, Eczema, Voltaren Gel, Monistat 7, Dermatitis, Clobetasol, Contact Dermatitis, Bactroban, Mupirocin, Therapeutic, Maintain, Hypercare, Drysol, Sulfur, Efudex, Fluocinonide, Retin-A, Epiduo

Eczema Cream for Children Not a Cancer Risk, Study Finds

Posted 18 Feb 2015 by Drugs.com

WEDNESDAY, Feb. 18, 2015 – A cream used to treat the skin condition eczema in children does not appear to increase the risk of cancer, according to a study funded by the maker of the cream. Researchers looked at nearly 7,500 children in the United States who were given an average of 793 grams of pimecrolimus (Elidel) cream to treat eczema and were followed for 10 years. As of May 2014, five cases of cancer were diagnosed among the children: two leukemias, two lymphomas and one bone cancer. There were no cases of skin cancer, the researchers said. Based on the findings, "it seems unlikely" that pimecrolimus cream as used in the study to treat eczema is associated with an increased risk of cancer, lead researcher Dr. David Margolis, from the University of Pennsylvania in Philadelphia, and colleagues concluded. The study was published online Feb. 18 in the journal JAMA Dermatology and was ... Read more

Related support groups: Eczema, Dermatitis, Contact Dermatitis, Atopic Dermatitis, Elidel, Pimecrolimus

FDA Medwatch Alert: Elidel Cream (pimecrlimus)

Posted 20 Jan 2006 by Drugs.com

[Posted 01/20/2006] The Food and Drug Administration announced the approval of updated labeling for two topical eczema drugs, Elidel Cream (pimecrolimus) and Protopic Ointment (tacrolimus). The labeling will be updated with a boxed warning about a possible risk of cancer and a Medication Guide (FDA-approved patient labeling) will be distributed to help ensure that patients using these prescription medicines are aware of this concern. The new labeling also clarifies that these drugs are recommended for use as second-line treatments. This means that other prescription topical medicines should be tried first. Use of these drugs in children under 2 years of age is not recommended. p> [January 19, 2006 – Protopic Information Page – FDA] [January 27, 2006 – Elidel letter – FDA] Read more

Related support groups: Elidel

FDA Medwatch Alert: Elidel (pimecrolimus)

Posted 10 Mar 2005 by Drugs.com

The FDA issued a public health advisory to inform healthcare providers and patients about a potential cancer risk from use of Elidel (pimecrolimus) and Protopic (tacrolimus), products that are applied to the skin. This concern is based on information from animal studies, case reports in a small number of patients, and how these drugs work. It may take human studies of ten years or longer to determine if use of Elidel or Protopic is linked to cancer. In the meantime, this risk is uncertain and FDA advises that Elidel and Protopic should be used only as labeled, for patients who have failed treatment with other therapies.[March 10, 2005 - Public Health Advisory - FDA][March 10, 2005 - Talk Paper - FDA][March 10, 2005 - Elidel Drug Information Page - FDA][March 10, 2005 - Protopic Drug Information Page - FDA] Read more

Related support groups: Elidel

Ask a Question

Further Information

Related Condition Support Groups

Perioral Dermatitis, Eczema, Contact Dermatitis, Atopic Dermatitis

Elidel Patient Information at Drugs.com